EUVIMEDEUVIMED entdecken
Open Access

Metabolic Dysregulation and Cancer Risk Program (MeDOC): a transdisciplinary approach to obesity-associated cancers

Tram Kim Lam iD, Phil Daschner, Naoko Ishibe, Anil Wali, Kara Hall, Susan Czajkowski, Somdat Mahabir, Joanna M Watson, Linda Nebeling, Sharon Ross, Edward Sauter

JNCI: Journal of the National Cancer Institute · 2024

DOI: 10.1093/jnci/djae134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Tram Kim Lam und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA. Hauptthemen laut MEDLINE: Obesity, Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI, NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the escalating prevalence of obesity, the association between obesity and cancer is a growing public health concern. Obesity will soon surpass tobacco smoking as the most important preventable cause of cancer. Obesity-driven mechanisms can alter cell functions to induce metabolic changes, chronic inflammation, and insulin resistance that are believed to contribute to cancer risk and development; yet the specific underlying biological mechanisms of obesity-related cancer development are largely unknown. The Metabolic Dysregulation and Cancer Risk Program: a transdisciplinary approach to obesity-associated cancers (MeDOC) is a trans–National Cancer Institute research initiative supported by the Division of Cancer Control and Population Sciences, the Division of Cancer Biology, the Division of Cancer Prevention, and the Center to Reduce Cancer Health Disparities. The overall purpose of the MeDOC Program is to advance our understanding of the underlying mechanisms that connect obesity, metabolic dysregulation, and increased obesity cancer risk as well as identify markers that will enhance cancer risk prediction, improve screening for high-risk individuals, and identify targets for preventive and therapeutic interventions for cancer interception or treatment. This report describes the funded research projects, the Coordinating Center, and the goals of the MeDOC program.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityNeoplasmsHumansUnited StatesRisk FactorsInsulin ResistanceNational Cancer Institute (U.S.)InflammationRisk AssessmentInterdisciplinary Research

Autor:innen und Institutionen

  • Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.
  • Division of Cancer Biology, National Cancer Institute, Rockville, MD, USA.
  • Center to Reduce Cancer Health Disparities, National Cancer Institute, Rockville, MD, USA.
  • Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA.

ORCID-Profile: Tram Kim Lam

Förderung

  • NCI
  • NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Lam, T. K., Daschner, P., Ishibe, N., Wali, A., Hall, K., Czajkowski, S., Mahabir, S., Watson, J. M., Nebeling, L., Ross, S., & Sauter, E. (2024). Metabolic Dysregulation and Cancer Risk Program (MeDOC): a transdisciplinary approach to obesity-associated cancers. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae134

Vancouver

Lam TK, Daschner P, Ishibe N, Wali A, Hall K, Czajkowski S, et al. Metabolic Dysregulation and Cancer Risk Program (MeDOC): a transdisciplinary approach to obesity-associated cancers. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae134

BibTeX
@article{Lam2024,
  author = {Lam, Tram Kim and Daschner, Phil and Ishibe, Naoko and Wali, Anil and Hall, Kara and Czajkowski, Susan and Mahabir, Somdat and Watson, Joanna M and Nebeling, Linda and Ross, Sharon and Sauter, Edward},
  title = {Metabolic Dysregulation and Cancer Risk Program (MeDOC): a transdisciplinary approach to obesity-associated cancers},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2024},
  doi = {10.1093/jnci/djae134}
}
Kostenlos starten →